14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
WOR vs RYI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, Worthington Enterprises, Inc. (WOR) is the stronger overall head-to-head candidate over Ryerson Holding Corporation (RYI) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). WOR carries a Unified Composite Score of 61.1/100 (BUY) at $57.77 (15.1x Forward P/E, 6.2% operating margin), whereas RYI carries 61.3/100 (BUY) at $28.16 (16.7x Forward P/E, -3.3% operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on WOR vs RYI. Trailing 12-month operating profitability (WOR 6.2% vs RYI -3.3%) and valuation multiples (WOR 15.1x vs RYI 16.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Metal Fabrication value chain with $901.0M market capitalization and -3.3% operating margin.
OpEx & R&D Reinvestment20.4% of Rev ($933M)
90D Engineering Disclosures0 Published
Investor FAQ WOR vs RYI Key Questions & Quantitative Answers
As of Nov 17, 2026, Worthington Enterprises, Inc. (WOR) is the stronger overall head-to-head candidate over Ryerson Holding Corporation (RYI) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). WOR carries a Unified Composite Score of 61.1/100 (BUY) at $57.77 (15.1x Forward P/E, 6.2% operating margin), whereas RYI carries 61.3/100 (BUY) at $28.16 (16.7x Forward P/E, -3.3% operating margin). Technically, WOR sits in a Neutral phase (RSI 39.1, CONSOLIDATION options structure) and RYI sits in a Markup phase (RSI 52.6, UNCLASSIFIED options structure).
WOR leads the Growth & Scale pillar: WOR posts +13.2% YoY revenue growth and +24.3% YoY earnings growth on $1.42B TTM revenue (27.4% gross margin, 6.2% operating margin), compared with RYI at +9.7% YoY revenue growth and -79.6% YoY earnings growth on $4.57B TTM revenue (17.1% gross margin, -3.3% operating margin). On trailing 12-month operating scale, WOR generates $1.42B in USD-normalized revenue versus $4.57B for RYI. In operating R&D and SG&A reinvestment, WOR deploys 21.2% of Rev ($301M) (0 90-day corporate R&D disclosures) versus 20.4% of Rev ($933M) (0 disclosures) for RYI.
WOR screens cheaper on headline valuation multiples. WOR trades at 15.1x Forward P/E, 18.0x Trailing P/E, 1.97x PEG, and 2.3x EV/Revenue (13.8% FCF margin), whereas RYI trades at 16.7x Forward P/E, N/M Trailing P/E, 0.35x PEG, and 0.2x EV/Revenue (1.1% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against WOR (16.2% ROE) versus RYI (-6.9% ROE) capital efficiency.
In options market volatility and institutional positioning, WOR carries 39.7% implied volatility (9th %ile, Compressed (<25th %ile)), a 1.40x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.92β · 37% Vol realized risk). By comparison, RYI carries 43.9% implied volatility (3rd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.38β · 82% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.